| Molecular screening for T315I and F317L resistance mutations in Iraqi chronic myeloid leukemia non-responders patients to imatinib MAR Dhahi, BF Matti, S Fadel Cancer Clin Oncol 2 (2), 55-61, 2013 | 8 | 2013 |
| Assessment of Interleukin 1β Serum Level in Different Responder Groups and Stages of Chronic Myeloid Leukemia Patients on Imatinb Mesylate Therapy BF Matti, MA Saleem, SF Sabir Indian Journal of Hematology and Blood Transfusion 30 (4), 247-252, 2014 | 7 | 2014 |
| The Correlation of Lipocalin-2 and Retinol Binding Protein-4 with the Inflammatory State in Iraqi Patients with T2DM SA Wadood, RS Al-Shawk, SF Sabir Iraqi Journal of Science 57 (2A), 802-807, 2016 | 4 | 2016 |
| Incidence of JAK2 V617F Mutation in Iraqi Patients with Philadelphia Positive CML Marwah Hasan Ali Al-Kaabi, Yusra Ghiath Yaseen Al-Obaidy, Shahla'a Fadhil ... Mintage Journal of Pharmaceutical & Medical Sciences 2 (4), 10-12, 2013 | 4* | 2013 |
| Serum Calcium And Phosphateleveelsin Patients With Chronic Myeloid Leukemia Taking Different Dose of Tyrosine Kinase Inhibitors BF Matti, SF Sabir, MA Abdul Khaleq, MH Al Kaabi Al-Mustansiriyah Journal of Pharmaceutical Sciences (AJPS) 17 (1), 213-221, 2018 | 3 | 2018 |
| Assessment of GM-CSF Level in the Serum of Patients with Different Stages of Chronic Myeloid Leukemia Befor and After Imatinb Mesylate Therapy SF Sabir, MA Saleem, BF Matti Iraqi J. Hematology 2 (1), 7-13, 2013 | 3 | 2013 |
| Characteristic of CD4+CD25+ T Cells in Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate with Different BCR-ABL Transcripts Levels Response SF Sabir, WMA Alwatar, BF Matti Medico-legal Update 21 (1), 949-955, 2021 | 2 | 2021 |
| Assessment of regulatory T cells (Tregs) and Foxp3 methylation level in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy SF Sabir, BF Matti, WMA Alwatar Immunogenetics 75 (2), 145-153, 2023 | 1 | 2023 |
| Impact of programmed death 1 expression in chronic myeloid leukemia at different molecular responses to imatinib mesylate treatment SF Sabir, WMA Alwatar, BF Matti Biochem. Cell. Arch. 21 (1), 671-678, 2021 | | 2021 |
| INTERLEUKIN 1β LEVEL AND C- REACTIVE PROTEIN ROLES IN PRIMARY MYELOFIBROSIS PATIENTS TREATED WITH HYDROXYUREA AND RUXOLITINIB Bassam Francis Matti, Shahla'a Fadhil Sabir, Maysaa Ali Abdul Khaleq, Marwah ... Int. Res. J. Pharm. 8 (6), 30-34, 2017 | | 2017 |
| Assessment of interleukin-10 level and Janus kinase 2 V617F mutation incidence in patients with primary myelofibrosis SF Sabir Iraqi Journal of Hematology 5 (2), 178, 2016 | | 2016 |
| Discrimination of types of hypochromic microcytic anemia using screening laboratory test Abdulsalam Hatim Mohammed, Alea Frahan Salman, Shahla̛a Fadhil Sabir International Journal of Innovative and Applied Research 3 (2), 8-11, 2015 | | 2015 |
| Efficacy and Tolerance of Fludarabine and Cyclophosphamide (FC) Combination Regimen in advance stage of Chronic Lymphocytic Leukemia BF Matti, AS Naji, AF Alwan, AF Majeed, S Saber Jordan Medical Journal 47 (4), 298-307, 2013 | | 2013 |
| Combination therapy of Fludarabine and Cyclophosphamide(FC) Combination Regimen in advance stage of Chronic Lymphocytic Leukemia BF Matti, AS Naji, AF Majid, SF Sabir, AF Alwan JFacMedBagdad 55 (1), 28-32, 2013 | | 2013 |
Refif Sabih Al-ShawkMicrobiology department \ College of medicine \ Mustansiriyah universityVerified email at uomustansiriyah.edu.iq
